{"id":84809,"topic":"peptides","source":"finance.sina.com.cn","title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","url_hash":"f57e6bfec70909428bbe312c8940fe8aa397d387","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPVmhpYVVMXzEzT1dZWDVQX1lnOHdOaWR0OUZTczR4Ymk5SU54MUdfZTY1TzFlUG1MS1d4YnNRblp3OFFvUk1CSWUwbmN5Q2dYQTl2dld2RERQN2JUcDlUekgwZTlCZjU3OUQzdGdRbUh6d0t5VnRhbExKYkhxLXFkZUp0bWg?oc=5\" target=\"_blank\">甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">finance.sina.com.cn</font>","content":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","image_url":"//n.sinaimg.cn/spider20260907/50/w1080h570/20260907/6f33-b3be31bc06bc3763d708e73f5d23b605.jpg","lang":"zh","published_at":"2026-09-07T07:00:00+00:00","fetched_at":"2026-09-17T21:15:12+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2708 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2708,"summary_length":2708,"usable_text_length":2708,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2708,"summary_length":2708}},"news_item":{"id":84809,"canonical_url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","source_url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","source_name":"finance.sina.com.cn","author":null,"published_at":"2026-09-07T07:00:00+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPVmhpYVVMXzEzT1dZWDVQX1lnOHdOaWR0OUZTczR4Ymk5SU54MUdfZTY1TzFlUG1MS1d4YnNRblp3OFFvUk1CSWUwbmN5Q2dYQTl2dld2RERQN2JUcDlUekgwZTlCZjU3OUQzdGdRbUh6d0t5VnRhbExKYkhxLXFkZUp0bWg?oc=5\" target=\"_blank\">甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">finance.sina.com.cn</font>","full_text":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","excerpt":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 2708 characters.","diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2708 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2708,"summary_length":2708,"usable_text_length":2708,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2708,"summary_length":2708}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","summary":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","source":"finance.sina.com.cn","date":"2026-09-07T07:00:00+00:00","content":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 2708 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2708 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2708,"summary_length":2708,"usable_text_length":2708,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2708,"summary_length":2708}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/84809","export_markdown":"/api/items/84809/export?format=markdown","export_json":"/api/items/84809/export?format=json","diagnose":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp"},"formats":{"full":{"id":84809,"title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","source":"finance.sina.com.cn","author":null,"published_at":"2026-09-07T07:00:00+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","full_text":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 2708 characters.","diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2708 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2708,"summary_length":2708,"usable_text_length":2708,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2708,"summary_length":2708}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2708 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2708,"summary_length":2708,"usable_text_length":2708,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2708,"summary_length":2708}},"actions":{"read":"/item/84809","export_markdown":"/api/items/84809/export?format=markdown","export_json":"/api/items/84809/export?format=json","diagnose":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp"}},"digest":{"id":84809,"title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","source":"finance.sina.com.cn","topic":"peptides","published_at":"2026-09-07T07:00:00+00:00","excerpt":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸ 2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 2708 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","subtitle":"finance.sina.com.cn · 2026-09-07","summary":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸ 2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è…","badges":["quality:high"],"links":{"read":"/item/84809","original":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","diagnose":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp"},"quality_warning":null},"export":{"title":"甘李药业口服多肽GLP-1RA周制剂GZC8072片I期临床研究完成首例试验参与者给药 - finance.sina.com.cn","url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml?froms=ggmp","summary":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","source":"finance.sina.com.cn","date":"2026-09-07T07:00:00+00:00","content":"ï¼æ¥æºï¼åæ°æ¢ç´¢ç çæè¯ä¸\n2026å¹´9æ7æ¥ï¼çæè¯ä¸è¡ä»½æéå ¬å¸ï¼ä»¥ä¸ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼å®£å¸ï¼å ¬å¸èªä¸»ç åçè¶ é¿æå£æå¤è½GLP-1RAå¨å¶åGZC8072çï¼å¨å¥åº·è¯éªåä¸è ä¸å次ç»è¯åå¨è¥è/è¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯çä¸å½â æ临åºç 究ï¼å·²äºè¿æ¥å®æé¦ä¾è¯éªåä¸è ç»è¯ãè¿æ å¿ç该款åæ°äº§åçç åæ£å¼è¿å ¥ä¸´åºé¶æ®µãç®åï¼GZC8072çå·²è·æ¹å¼å±è¥è/è¶ éå2åç³å°¿ç 两项éåºçç临åºç 究ã\næ¬ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå¹³è¡ãå®æ °åå¯¹ç §çIæ临åºç 究ï¼è¯ç©ä¸´åºè¯éªç»è®°ä¸ä¿¡æ¯å ¬ç¤ºå¹³å°ï¼CTR20263271ï¼ï¼æ¨å¨è¯ä»· GZC8072 çå¨å¥åº·æå¹´è¯éªåä¸è ä¸å次ç»è¯åå¨è¥èæè¶ éè¯éªåä¸è ä¸å¤æ¬¡ç»è¯åçå®å ¨æ§åèåæ§ã该ç 究æçº³å ¥112ä¾è¯éªåä¸è ï¼çéåæ ¼çè¯éªåä¸è å°æ¥åGZC8072çæå®æ °åå次æå¤æ¬¡ç»è¯ã\nGZC8072ççç åä¾æäºçæè¯ä¸èªä¸»æ建çä¸¤å¤§æ ¸å¿ææ¯å¹³å°ââNovaPeptideåSupOraTideï¼åè ä¸æ³¨äºè§£å³å¤è½è¯ç©çé¿æåå¼ååç产é®é¢ï¼èåè åè´åäºæ»å å¤è½è¯ç©çå£æç»è¯é¾é¢ãä½ä¸ºå ¬å¸å¤è½è¯ç©ç åä½ç³»ç主è¦æ¯æï¼ä¸¤å¤§å¹³å°ååä½ç¨ï¼ä½¿GZC8072çå¨æåååæ´»æ§ã延é¿åè¡°æçåæ¶ï¼è½å¤æ¾èæ¹åå£æçç©å©ç¨åº¦ï¼ææå®ç°æ¯å¨ä¸æ¬¡å£æç»è¯çæ¹æ¡ã\nå ³äºGZC8072ç\nGZC8072çæ¯çæè¯ä¸åºäºå¤©ç¶GLP-1èªä¸»ç åç1ç±»åæ°åååè¶ é¿æå£æå¤è½GLP-1 RAå¨å¶åï¼æ¥æç¬ç«ç¥è¯äº§æï¼æå¼åéåºçå æ¬2åç³å°¿ç åè¥èæè¶ éçä½é管çãGZC8072ççå¼åä¾æçæè¯ä¸åæ°æ§NovaPeptide å¤è½ææ¯å¹³å°åSupOraTideå£æå¤è½ææ¯å¹³å°ï¼è½å¤æ¾è延é¿åååè¡°æãå¢å¼ºçç©æ´»æ§ï¼å¹¶å¤§å¹ æåå£æçç©å©ç¨åº¦ã临åºåç 究ç»ææ¾ç¤ºï¼GZC8072çå ·æè¯å¥½çè¯æå¨åå¦åè¯ä»£å¨åå¦ç¹å¾ï¼ä¸å®å ¨æ§è¯å¥½ãç®åï¼GZC8072ççå ¨çå¼åå·²è¿å ¥Iæ临åºç 究é¶æ®µã\nåç»æ§å£°æ\n该åç»æ§éè¿°åºäºæ们å¨éè¿°ä¹æ¥çé¢æåå设ãç±äºåç§å ç´ ï¼å®é ç»æå¯è½ä¸è¿äºåç»æ§éè¿°ä¸è¡¨è¾¾çå 容åå¨é大差å¼ï¼æ们ä¸è½ä¿è¯å°æ¥ä¼å®ç°è¿äºç»æãæ们ä¸æ¿æ æ´æ°æä¿®æ¹ä»»ä½åç»æ§éè¿°çä¹å¡ï¼æ 论æ¯ç±äºæ°ä¿¡æ¯ãæªæ¥äºä»¶æå ¶ä»åå ã\nå ³äºçæè¯ä¸\nçæè¯ä¸è¡ä»½æéå ¬å¸ï¼ç®ç§°ï¼çæè¯ä¸ï¼è¡ç¥¨ä»£ç ï¼603087.SHï¼ä½ä¸ºä¸å½ç¬¬ä¸å®¶ææ¡äº§ä¸åç产éç»è°å²ç´ 类似ç©ææ¯çé«ç§æçç©å¶è¯ä¼ä¸ï¼å ·å¤å®æ´è°å²ç´ ç å管线ã\nç®åï¼å ¬å¸æ¥æå æ¬¾æ ¸å¿è°å²ç´ 产åï¼å æ¬äºä¸ªè°å²ç´ 类似ç©åç§ï¼é¿æçç²¾è°å²ç´ 注å°æ¶²ï¼é¿ç§é®ï¼ãéæèµè¯è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¨å¬è°å²ç´ 注å°æ¶²ï¼éç§é®ï¼ãé¢æ··ç²¾èç½ééç»èµè¯è°å²ç´ æ··å注å°æ¶²ï¼25Rï¼ï¼éç§é®25ï¼ãé¨å¬è°å²ç´ 30注å°æ¶²ï¼éç§é®30ï¼ï¼ä»¥å人è°å²ç´ åç§ï¼é¢æ··ç²¾èç½äººè°å²ç´ æ··å注å°æ¶²ï¼30Rï¼ï¼æ®ç§é®30ï¼åç¸å ³é å¥å¨æ¢°ï¼äº§åè¦çé¿æãéæãé¢æ··ä¸ä¸ªè°å²ç´ åè½ç»åå¸åºã\nçæè¯ä¸å¨ä¸å½è°å²ç´ 第äºæ¬¡éä¸å¸¦ééè´ä¸ï¼è°å²ç´ 类似ç©ä¸éåè®®éå± ä¸éä¼ä¸é¦ä½ï¼å½å å¸åºåºç¡æç»å¤¯å®ãä¸æ¤åæ¶ï¼å ¬å¸å½é åè¿ç¨ç¨³æ¥æ¨è¿ï¼çç²¾è°å²ç´ 注å°æ¶²ãèµè¯è°å²ç´ 注å°æ¶²åé¨å¬è°å²ç´ 注å°æ¶²åå·²è·å¾æ¬§çå§åä¼ï¼ECï¼ä¸å¸æ¹åï¼æ£ç¨³æ¥åå ¨ç代谢ç¾ç é¢åæ ¸å¿åä¸è è¿è¿ã\næªæ¥ï¼çæå°åªåå®ç°ç³å°¿ç æ²»çé¢åçå ¨é¢è¦çï¼è¿ä¸æ¥æåå ¬å¸å¨ç³å°¿ç æ²»çé¢åçå¸åºç«äºåãå ¬å¸è¿å°ç§¯æå¼åæ°çåå¦è¯åçç©æ°è¯ï¼éç¹å ³æ³¨ä»£è°¢æ§ç¾ç ãå¿è¡ç®¡ç¾ç åå ¶ä»æ²»çé¢åã\nVIP课ç¨æ¨è\nAPPä¸äº«ç´æ\nçé¨æ¨è\næ¶èµ·24å°æ¶æ»å¨ææ¥ææ°çè´¢ç»èµè®¯åè§é¢ï¼æ´å¤ç²ä¸ç¦å©æ«æäºç»´ç å ³æ³¨ï¼sinafinanceï¼","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6298181.shtml%3Ffroms%3Dggmp","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 2708 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 2708 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":2708,"summary_length":2708,"usable_text_length":2708,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":2708,"summary_length":2708}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}